Mr Christopher D. Christian > Dechert LLP > Boston, United States > Lawyer Profile
Dechert LLP Offices
ONE INTERNATIONAL PLACE
40TH FLOOR, 100 OLIVER STREET
BOSTON, MA 02110-2605
MASSACHUSETTS
United States
- Firm Profile
- Go to...
Mr Christopher D. Christian
Work Department
Financial Services and Investment Management
Career
Christopher D. Christian advises U.S. and European asset managers and investment funds and their boards of directors, including U.S. registered funds, funds organized under the European Union directive on Undertakings for Collective Investment in Transferable Securities (UCITS), and funds organized in other jurisdictions offered on a private basis.
Mr. Christian’s practice has a significant international component. He advises offshore funds on compliance with U.S. regulatory requirements and routinely counsels European retail and institutional funds on organization, registration, corporate governance, and global distribution issues. He has assisted clients in coordinating offering advisory services and various types of investment funds in compliance with local law in jurisdictions in Europe, Asia, the Middle East, and Latin and South America.
Memberships
International Bar Association
Education
- Brandeis University, B.A., 1995
- The Catholic University of America, Columbus School of Law, J.D., 1998, cum laude
- Georgetown University Law Center, LL.M., Securities and Financial Regulation, 1999
Comparative Guides
| United States: Alternative Investment Funds | September 2022 | This country-specific Q&A provides an overview to Alternative Investment Funds laws and regulations that may occur in United States. |
Top Tier Firm Rankings
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Real estate > Real estate finance
Firm Rankings
- Dispute resolution > General commercial disputes
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Finance > Structured finance: securitization
- Antitrust > Civil litigation/class actions: defense
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > E-discovery
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Industry focus > Healthcare: life sciences
- Dispute resolution > International litigation
- Tax > International tax
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- M&A/corporate and commercial > Private equity buyouts
- Finance > Restructuring (including bankruptcy): corporate
- Intellectual property > Trademarks: non-contentious (including prosecution, portfolio management and licensing)
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- Finance > Capital markets: high-yield debt offerings
- Labor and employment > Employee benefits, executive compensation and retirement plans: design
- Industry focus > Environment: transactional
- Media, technology and telecoms > Fintech
- Dispute resolution > International arbitration
- International Trade > International trade
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- Dispute resolution > Leading trial lawyers
- Intellectual property > Patents: litigation (full coverage)
- Investment fund formation and management > Private equity funds (including venture capital)
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense